Orthobiologics Market

Orthobiologics Market (Product - Bone Morphogenetic Proteins, Demineralized Bone Matrix, Synthetic Bone Substitutes, Viscosupplements, Allografts, Stem Cell; Application - Spinal Fusion, Trauma Repair, Reconstructive Surgeries; End user - Hospitals, Orthopedic Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • Rep Id : TMRGL1747
  • Published On : Feb 2019
  • No. of Pages : 251
  • Category : Healthcare

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights
 
2. Assumptions and Research Methodology
 
3. Executive Summary: Global Orthobiologics Market
 
4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
                     4.3.1.1 Rise in Prevalence of Chronic Arthritis
                     4.3.1.2 Surge in Sports Injuries
                     4.3.1.3 Demand for Innovative Product
            4.3.2. Restraints
                     4.3.2.1 Lack of Reimbursement 
                     4.3.2.2 Stringent Regulatory Requirement
            4.3.3. Opportunities
                     4.3.3.1 Increase in focus on stem cell based matrices
                     4.3.3.2 Launch of new products and acquisition in emerging markets
     4.4. Global Orthobiologics Market Analysis and Forecast, 2016–2026
 
5. Key Insights
     5.1.Key Market Trends
     5.2. Merger and Acquisition
     5.3 Strategies of Top Five Players Operating in the Market 
     5.4 Incidence of Orthopedic Disorder, by Key Countries
     5.5. Regulatory and Reimbursement Scenario, by Key Countries 
 
6. Global Orthobiologics Market Analysis and Forecast, by Product      
     6.1. Introduction & Definition
     6.2. Market Value Forecast, by Product, 2016–2026
            6.2.1. Demineralized Bone Matrix
            6.2.2. Allografts
            6.2.3. Synthetic Bone Substitutes 
            6.2.4. Viscosupplements 
            6.2.5. Bone Morphogenetic Proteins
            6.2.6. Stem Cell Therapy 
            6.2.7. Others
     6.4. Market Attractiveness, by Product 
 
7. Global Orthobiologics Market Analysis and Forecast, by Application 
     7.1. Introduction & Definition
     7.2. Market Value Forecast, by Application, 2016–2026
            7.2.1. Spinal Fusion 
            7.2.2. Trauma Repair 
            7.2.3. Reconstructive Surgeries
            7.2.4. Others 
     7.3. Market Attractiveness, by Application 
 
8. Global Orthobiologics Market Analysis and Forecast, by End-user 
     8.1. Introduction & Definition
     8.2. Market Value Forecast, by End-user, 2016–2026
           8.2.1. Hospitals
           8.2.2. Orthopedic Clinics 
           8.2.3. Others 
     8.3. Market Attractiveness, by End-user 
 
9. Global Orthobiologics Market Analysis and Forecast, by Region
     9.1. Key Findings
     9.2. Market Value Forecast, by Region
            9.2.1. North America 
            9.2.2. Europe 
            9.2.3. Asia Pacific 
            9.2.4. Latin America 
            9.2.5. Middle East & Africa 
     9.3. Market Attractiveness, by Country/Region
 
10. North America Orthobiologics Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. Market Value Forecast, by Product, 2016–2026
            10.2.1. Demineralized Bone Matrix
            10.2.2. Allografts
            10.2.3. Synthetic Bone Substitutes 
            10.2.4. Viscosupplements
            10.2.5. Bone Morphogenetic Proteins
            10.2.6. Stem Cell Therapy 
            10.2.7. Others
     10.3. Market Value Forecast, by Application, 2016–2026
            10.3.1. Spinal Fusion 
            10.3.2. Trauma Repair 
            10.3.3. Reconstructive Surgeries
            10.3.4. Others 
     10.4. Market Value Forecast, by End-user, 2016–2026
            10.4.1. Hospitals
            10.4.2. Orthopedic Clinics 
            10.4.3. Others 
     10.5. Market Value Forecast, by Country, 2016–2026
            10.5.1. U.S.
            10.5.2. Canada
     10.6. Market Attractiveness Analysis 
            10.6.1. By Product 
            10.6.2. By Application 
            10.6.3. By End-user 
            10.6.4. By Country
 
11. Europe Orthobiologics Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
     11.2. Market Value Forecast, by Product, 2016–2026
            11.2.1. Demineralized Bone Matrix
            11.2.2. Allografts
            11.2.3. Synthetic Bone Substitutes 
            11.2.4. Viscosupplements 
            11.2.5. Bone Morphogenetic Proteins
            11.2.6. Stem Cell Therapy 
            11.2.7. Others
     11.3. Market Value Forecast, by Application, 2016–2026
            11.3.1. Spinal Fusion 
            11.3.2. Trauma Repair 
            11.3.3. Reconstructive Surgeries
            11.3.4. Others 
     11.4. Market Value Forecast, by End-user, 2016–2026
            11.4.1. Hospitals
            11.4.2. Orthopedic Clinics 
            11.4.3. Others 
     11.5. Market Value Forecast, by Country/Sub-region, 2016–2026
            11.5.1. Germany
            11.5.2. U.K.
            11.5.3. France
            11.5.4. Spain
            11.5.5. Italy
            11.5.6. Rest of Europe
     11.6. Market Attractiveness Analysis 
            11.6.1. By Product 
            11.6.2. By Application 
            11.6.3. By End-user 
            11.6.4. By Country/Sub-region
 
12. Asia Pacific Orthobiologics Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
     12.2. Market Value Forecast, by Product , 2016–2026
            12.2.1. Demineralized Bone Matrix
            12.2.2. Allografts
            12.2.3. Synthetic Bone Substitutes 
            12.2.4. Viscosupplements 
            12.2.5. Bone Morphogenetic Proteins
            12.2.6. Stem Cell Therapy 
            12.2.7. Others
     12.3. Market Value Forecast, by Application, 2016–2026
            12.3.1. Spinal Fusion 
            12.3.2. Trauma Repair 
            12.3.3. Reconstructive Surgeries
            12.3.4. Others 
     12.4. Market Value Forecast, by End-user, 2016–2026
            12.4.1. Hospitals
            12.4.2. Orthopedic Clinics 
            12.4.3. Others 
     12.5. Market Value Forecast, by Country/Sub-region, 2016–2026
            12.5.1. China
            12.5.2. Japan
            12.5.3. India
            12.5.4. Australia & New Zealand
            12.5.5. Rest of Asia Pacific
     12.6. Market Attractiveness Analysis 
            12.6.1. By Product 
            12.6.2. By Application 
            12.6.3. By End-user 
            12.6.4. By Country/Sub-region
 
13. Latin America Orthobiologics Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
     13.2. Market Value Forecast, by Product, 2016–2026
            13.2.1. Demineralized Bone Matrix
            13.2.2. Allografts
            13.2.3. Synthetic Bone Substitutes 
            13.2.4. Viscosupplements 
            13.2.5. Bone Morphogenetic Proteins
            13.2.6. Stem Cell Therapy 
            13.2.7. Others
     13.3. Market Value Forecast, by Application, 2016–2026
            13.3.1. Spinal Fusion 
            13.3.2. Trauma Repair
            13.3.3. Reconstructive Surgeries
            13.3.4. Others 
     13.4. Market Value Forecast, by End-user, 2016–2026
            13.4.1. Hospitals
            13.4.2. Orthopedic Clinics 
            13.4.3. Others 
     13.5. Market Value Forecast, by Country/Sub-region, 2016–2026
            13.5.1. Brazil
            13.5.2. Mexico
            13.5.3. Rest of Latin America
     13.6. Market Attractiveness Analysis 
            13.6.1. By Product 
            13.6.2. By Application 
            13.6.3. By End-user 
            13.6.4. By Country/Sub-region
 
14. Middle East & Africa Orthobiologics Market Analysis and Forecast
     14.1. Introduction
            14.1.1. Key Findings
     14.2. Market Value Forecast, by Product, 2016–2026
            14.2.1. Demineralized Bone Matrix
            14.2.2. Allografts
            14.2.3. Synthetic Bone Substitutes 
            14.2.4. Viscosupplements 
            14.2.5. Bone Morphogenetic Proteins
            14.2.6. Stem Cell Therapy 
            14.2.7. Others
     14.3. Market Value Forecast, by Application, 2016–2026
            14.3.1. Spinal Fusion 
            14.3.2. Trauma Repair
            14.3.3. Reconstructive Surgeries
            14.3.4. Others 
     14.4. Market Value Forecast, by End-user, 2016–2026
            14.4.1. Hospitals
            14.4.2. Orthopedic Clinics 
            14.4.3. Others 
     14.5. Market Value Forecast, by Country/Sub-region, 2016–2026
            14.5.1. GCC Countries
            14.5.2. South Africa
            14.5.3. Rest of Middle East & Africa
     14.6. Market Attractiveness Analysis 
            14.6.1. By Product 
            14.6.2. By Application 
            14.6.3. By End-user 
            14.6.4. By Country/Sub-region
 
15. Competition Landscape
     15.1. Global Orthobiologics Market Analysis, by Top Company Ranking, 2017
     15.2. Global Orthobiologics Market Position Analysis, by Company
     15.3. Company Profiles
            15.3.1. Medtronic 
                     15.3.1.1 Company Overview 
                     15.3.1.2 Product Portfolio
                     15.3.1.3 SWOT Analysis
                     15.3.1.4 Financial Overview
                     15.3.1.5 Strategic Overview
            15.3.2. DePuy Synthes  (Johnson & Johnson) 
                     15.3.2.1 Company Overview 
                     15.3.2.2 Product Portfolio
                     15.3.2.3 SWOT Analysis
                     15.3.2.4 Financial Overview
                     15.3.2.5 Strategic Overview
            15.3.3. Sanofi  
                     15.3.3.1 Company Overview 
                     15.3.3.2 Product Portfolio
                     15.3.3.3 SWOT Analysis
                     15.3.3.4 Financial Overview
            15.3.4. Seikagaku Corporation  
                     15.3.4.1 Company Overview 
                     15.3.4.2 Product Portfolio
                     15.3.4.3 SWOT Analysis
                     15.3.4.4 Financial Overview
                     15.3.4.5 Strategic Overview
            15.3.5. Stryker
                     15.3.5.1 Company Overview 
                     15.3.5.2 Product Portfolio
                     15.3.5.3 SWOT Analysis
                     15.3.5.4 Financial Overview
                     15.3.5.5 Strategic Overview
            15.3.6. MTF Biologics 
                     15.3.6.1 Company Overview 
                     15.3.6.2 Product Portfolio
                     15.3.6.3 SWOT Analysis
            15.3.7. Bioventus LLC
                     15.3.7.1 Company Overview 
                     15.3.7.2 Product Portfolio
                     15.3.7.3 SWOT Analysis
                     15.3.7.4 Strategic Overview
            15.3.8. Arthrex
                     15.3.8.1 Company Overview 
                     15.3.8.2 Product Portfolio
                     15.3.8.3 SWOT Analysis
                     15.3.8.4 Strategic Overview
            15.3.9. Zimmer Biomet
                     15.3.9.1 Company Overview 
                     15.3.9.2 Product Portfolio
                     15.3.9.3 SWOT Analysis
                     15.3.9.4 Financial Overview 
                     15.3.9.5 Strategic Overview
            15.3.10 RTI Surgical, Inc.
                     15.3.10.1 Company Overview 
                     15.2.10.2 Product Portfolio
                     15.2.10.3 SWOT Analysis
                     15.2.10.4 Financial Overview 
                     15.3.10.5 Strategic Overview
            15.3.11. Alphatec Spine, Inc.
                     15.3.11.1 Company Overview 
                     15.3.11.2 Product Portfolio
                     15.3.11.3 SWOT Analysis
                     15.3.11.4 Financial Overview
                     15.3.11.5 Strategic Overview
            15.3.12. Exactech, Inc.
                     15.3.12.1 Company Overview 
                     15.3.12.2 Product Portfolio
                     15.3.12.3 SWOT Analysis
                     15.3.12.4 Financial Overview
                     15.3.12.5 Strategic Overview
            15.3.13. Globus Medical, Inc.
                     15.3.13.1 Company Overview 
                     15.3.13.2 Product Portfolio
                     15.3.13.3 SWOT Analysis
                     15.3.13.5 Financial Overview
                     15.3.13.6 Strategic Overview
            15.3.14. Integra LifeSciences
                     15.3.14.1 Company Overview 
                     15.3.14.2 Product Portfolio
                     15.3.14.3 SWOT Analysis
                     15.3.14.4 Financial Overview
                     15.3.14.5 Strategic Overview

List of Tables

Table 01: Global Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 03: Global Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 04: Global Orthobiologics Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America Orthobiologics Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 06: North America Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 07: North America Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 08: North America Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 09: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 10: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 11: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 12: Europe Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 13: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 14: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 15: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 16: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 17: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 18: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 19: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 20: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 21: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 23: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 24: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures

Figure 01: Global Orthobiologics Market Size (US$ Mn) and Distribution (%), by Region, 2018 and 2026
Figure 02: Global Orthobiologics Market Revenue (US$ Mn), by Product, 2017
Figure 03: Global Orthobiologics Market Value Share, by Product, 2017
Figure 04: Global Orthobiologics Market Value Share, by Application, 2017
Figure 05: Global Orthobiologics Market Value Share, by End-user, 2017
Figure 06: Global Orthobiologics Market Value Share, by Region, 2017
Figure 07: Global Orthobiologics Market Value (US$ Mn) Forecast, 2016–2026
Figure 08: Global Orthobiologics Market Value Share Analysis, by Product, 2017 and 2026
Figure 09: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Bone Morphogenetic Proteins, 2016–2026
Figure 10: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Demineralized Bone Matrix, 2016–2026
Figure 11: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Synthetic Bone Substitutes, 2016–2026
Figure 12: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Viscosupplements, 2016–2026
Figure 13: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Allografts, 2016–2026
Figure 14: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stem Cell, 2016–2026
Figure 15: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 16: Global Orthobiologics Market Attractiveness Analysis, by Product, 2018–2026
Figure 17: Global Orthobiologics Market Value Share Analysis, by Application, 2017 and 2026
Figure 18: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Spinal Fusion, 2016–2026
Figure 19: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Trauma Repair, 2016–2026
Figure 20: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Restorative Surgery, 2016–2026
Figure 21: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 22: Global Orthobiologics Market Attractiveness Analysis, by Application, 2018–2026
Figure 23: Global Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2026
Figure 24: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2016–2026
Figure 25: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Orthopedic Clinics, 2016–2026
Figure 26: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 27: Global Orthobiologics Market Attractiveness Analysis, by End-user, 2018–2026
Figure 28: Global Orthobiologics Market Value Share Analysis, by Region, 2017 and 2026
Figure 29: Global Orthobiologics Market Attractiveness Analysis, by Region, 2018–2026
Figure 30: North America Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 31: North America Orthobiologics Market Attractiveness Analysis, by Country, 2017–2026
Figure 32: North America Orthobiologics Market Value Share Analysis, by Country, 2017 and 2026
Figure 33: North America Orthobiologics Market Value Share Analysis, by Product, 2017 and 2026
Figure 34: North America Orthobiologics Market Value Share Analysis, by Application, 2017 and 2026
Figure 35: North America Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2026
Figure 36: North America Orthobiologics Market Attractiveness Analysis, by Product, 2017–2025
Figure 37: North America Orthobiologics Market Attractiveness Analysis, by Application, 2017–2025
Figure 38:North America Orthobiologics Market Attractiveness Analysis, by End-user, 2017–2025
Figure 39: Europe Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 40: Europe Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2026
Figure 41: Europe Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 42: Europe Orthobiologics Market Value Share Analysis, by Product, 2017 and 2026
Figure 43: Europe Orthobiologics Market Value Share Analysis, by Application, 2017 and 2026
Figure 44: Europe Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2026
Figure 45: Europe Orthobiologics  Market Attractiveness Analysis, by Product, 2017–2025
Figure 46: Europe Orthobiologics Market Attractiveness Analysis, by Application, 2017–2025
Figure 47: Europe Orthobiologics  Market Attractiveness Analysis, by End-user, 2017–2025
Figure 48: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 49: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2026
Figure 50: Asia Pacific Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 51: Asia Pacific Orthobiologics Market Value Share Analysis, by Product, 2017 and 2026
Figure 52: Asia Pacific Orthobiologics Market Value Share Analysis, by Application, 2017 and 2026
Figure 53: Asia Pacific Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2026
Figure 54: Asia Pacific Orthobiologics  Market Attractiveness Analysis, by Product, 2017–2025
Figure 55: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Application, 2017–2025
Figure 56: Asia Pacific Orthobiologics  Market Attractiveness Analysis, by End-user, 2017–2025
Figure 57: Latin America Orthobiologics Market Value  (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 58: Latin America Orthobiologics Market Attractiveness Analysis, by / Sub-region, 2017–2026
Figure 59: Latin America Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 60: Latin America Orthobiologics Market Value Share Analysis, by Product, 2017 and 2026
Figure 61: Latin America Orthobiologics Market Value Share Analysis, by Application, 2017 and 2026
Figure 62: Latin America Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2026
Figure 63: Latin America Orthobiologics  Market Attractiveness Analysis, by Product, 2017–2025
Figure 64: Latin America Orthobiologics Market Attractiveness Analysis, by Application, 2017–2025
Figure 65: Latin America Orthobiologics  Market Attractiveness Analysis, by End-user, 2017–2025
Figure 66: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 67: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2026
Figure 68: Middle East & Africa Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 69: Middle East & Africa Orthobiologics Market Value Share Analysis, by Product, 2017 and 2026
Figure 70: Middle East & Africa Orthobiologics Market Value Share Analysis, by Application, 2017 and 2026
Figure 71: Middle East & Africa Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2026
Figure 72: Middle East & Africa Orthobiologics  Market Attractiveness Analysis, by Product, 2017–2025
Figure 73: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Application, 2017–2025
Figure 74: Middle East & Africa Orthobiologics  Market Attractiveness Analysis, by End-user, 2017–2025
Figure 75: Global Orthobiologics Market Analysis, by Top Company Ranking, 2017
Figure 76: Global Orthobiologics Market Share, by Company, 2017
Figure 77: Medtronic Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 78: Medtronic Breakdown of Net Sales (%), by Region/Country, 2017
Figure 79: Medtronic Breakdown of Net Sales (%), by Business Segment, 2017
Figure 80: Medtronic R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 81: Johnson & Johnson Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 82: Johnson & Johnson Breakdown of Net Sales (%), by Region/Country, 2017
Figure 83: Johnson & Johnson Breakdown of Net Sales (%), by Business Segment, 2017
Figure 84: Johnson & Johnson R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 85: Sanofi Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 86: Sanofi Breakdown of Net Sales (%), by Region/Country, 2017
Figure 87: Sanofi Breakdown of Net Sales (%), by Business Segment, 2017
Figure 88: Sanofi R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 89: Seikagaku Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 90: Seikagaku Corporation Breakdown of Net Sales (%), by Region/Country, 2017
Figure 91: Seikagaku Corporation Breakdown of Net Sales (%), by Product Segment, 2017
Figure 92: Seikagaku Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 93: Stryker Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 94: Stryker Breakdown of Net Sales (%), by Region/Country, 2017
Figure 95: Stryker Breakdown of Net Sales (%), by Product Segment, 2017
Figure 96: Stryker R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 97: Zimmer Biomet Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 98: Zimmer Biomet Breakdown of Net Sales (%), by Region/Country, 2017
Figure 99: Zimmer Biomet Breakdown of Net Sales (%), by Product Segment, 2017
Figure 100: Zimmer Biomet R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 101: RTI Surgical, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 102: RTI Surgical, Inc. Breakdown of Net Sales (%), by Region/Country, 2017
Figure 103: RTI Surgical, Inc. Breakdown of Net Sales (%), by Product Segment, 2017
Figure 104: RTI Surgical, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 105: Alphatec Spine, Inc. Breakdown of Net Sales (%), by Region/Country, 2017
Figure 106: Alphatec Spine, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 107: Exactech, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 108: Exactech, Inc. Breakdown of Net Sales (%), by Region, 2016
Figure 109: Exactech, Inc. Breakdown of Net Sales (%), by Business Segment, 2016
Figure 110: Exactech, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2013-2016
Figure 111: Globus Medical, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 112: Globus Medical, Inc. Breakdown of Net Sales, by Region, 2017
Figure 113: Globus Medical, Inc. Breakdown of Net Sales, by Segment, 2017
Figure 114: Globus Medical, Inc. R&D Intensity and Sales & Marketing Intensity (%), 2016–2017
Figure 115: Integra LifeSciences Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 116: Integra LifeSciences Breakdown of Net Sales, by Region, 2017
Figure 117: Integra LifeSciences Breakdown of Net Sales, by Segment, 2017
Figure 118: Integra LifeSciences R&D Intensity and Sales & Marketing Intensity (%), 2016–2017

.